Neurophysiology of the Basal Ganglia, Thalamus, and Cerebellum in Patients With Movement Disorders
University of Pennsylvania
100 participants
Dec 10, 2025
INTERVENTIONAL
Conditions
Summary
The research study is being conducted to better understand parts of the human brain called the cortex, basal ganglia, thalamus, and cerebellum in patients with movement disorders (such as Parkinson's disease, essential tremor, dystonia, or ataxia). These brain structures are involved in movement disorders. This study attempts to better understand the brain electrical activity associated with these disorders, both in patients with and without deep brain stimulation (DBS). Recordings are made from the scalp with a noninvasive electrode and/or through the DBS stimulator if the participant has a stimulator model that is able to sense brain activity. These recordings are analyzed along with measures of movement disorder symptoms to identify brain signal signatures of symptoms.
Eligibility
Inclusion Criteria7
- Patients 18 years of age and above
- Any patient who has been diagnosed by a movement disorders neurologist with one of the following movement disorders:
- Parkinson's disease
- Dystonia
- Tremor, including essential tremor
- Cerebellar ataxia
- Other hyperkinetic movement disorders, such as chorea and tics
Exclusion Criteria1
- \- Patients with dementia
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
participant's movement disorders medications, prescribed by their treating physician
Deep brain stimulator parameters may be adjusted within normal clinical limits
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06848530